Nurix Therapeutics (NRIX) Prepaid Assets (2019 - 2026)

Nurix Therapeutics (NRIX) has reported Prepaid Assets for 8 consecutive years, with $13.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Prepaid Assets rose 22.78% year-over-year to $13.0 million; the TTM figure through May 2026 stood at $13.0 million (up 22.78% YoY), while the FY2025 annual figure was $13.9 million, up 41.55% from the prior year.
• Prepaid Assets eased to $13.0 million in Q2 2026 per NRIX's latest filing, from $13.7 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $14.0 million in Q1 2025 and bottomed at $7.0 million in Q1 2024.
• Historically, Prepaid Assets has averaged $10.2 million across 5 years, with a median of $10.1 million in 2022.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 177.38% — and 2024, when it slumped 37.62%.
• Nurix Therapeutics' Prepaid Assets stood at $9.3 million in 2022, then slipped by 18.4% to $7.6 million in 2023, then climbed by 29.08% to $9.8 million in 2024, then soared by 41.55% to $13.9 million in 2025, then decreased by 6.67% to $13.0 million in 2026.
• Business Quant data shows NRIX's Prepaid Assets at $13.0 million in Q2 2026, $13.7 million in Q1 2026, and $13.9 million in Q4 2025.